Published in Doc Ophthalmol on November 16, 2006
Inter-subject, inter-ocular and inter-session repeatability of the photopic negative response of the electroretinogram recorded using DTL and skin electrodes. Doc Ophthalmol (2010) 1.10
Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device. Clin Ophthalmol (2016) 0.80
Anti-γ-enolase autoimmune retinopathy manifesting in early childhood. Arch Ophthalmol (2010) 0.79
Early diagnosis of Stargardt disease with multifocal electroretinogram in children. Int Ophthalmol (2013) 0.79
A novel method to reduce noise in electroretinography using skin electrodes: a study of noise level, inter-session variability, and reproducibility. Int Ophthalmol (2016) 0.75
Comparing DTL microfiber and Neuroline skin electrode in the Mini Ganzfeld ERG. BMC Ophthalmol (2016) 0.75
The diagnosis and assessment of visual function in Singaporean children with electrophysiology: 10-year results. Doc Ophthalmol (2016) 0.75
Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA (1992) 37.26
Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ (1999) 14.34
Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ (1998) 8.34
Standard for clinical electroretinography (2004 update). Doc Ophthalmol (2004) 6.97
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
Clinical guidelines: developing guidelines. BMJ (1999) 6.01
Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol (2003) 4.53
Guidelines for basic pattern electroretinography. Recommendations by the International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (1997) 3.66
Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Doc Ophthalmol (2003) 3.59
Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med (1992) 3.48
Visual evoked potentials standard (2004). Doc Ophthalmol (2004) 2.75
Clinical guidelines: their implementation in general practice. Br J Gen Pract (1995) 2.67
Practice guidelines: a new reality in medicine. I. Recent developments. Arch Intern Med (1990) 2.53
Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (1993) 2.46
Standard for visual evoked potentials 1995. The International Society for Clinical Electrophysiology of Vision. Vision Res (1996) 2.10
Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol (1992) 1.92
Measurement of infant visual acuity from pattern reversal evoked potentials. Vision Res (1978) 1.41
The development of scotopic sensitivity. Invest Ophthalmol Vis Sci (2000) 1.07
Time courses for maturation of electroretinogram responses from infancy to adulthood. Doc Ophthalmol (2000) 1.00
Skin ERGs: their effectiveness in paediatric visual assessment, confounding factors, and comparison with ERGs recorded using various types of corneal electrode. Int J Psychophysiol (1994) 1.00
Development of the human visual system: monocular and binocular pattern VEP latency. Invest Ophthalmol Vis Sci (1991) 0.99
A comparison of flash electroretinograms recorded from Burian Allen, JET, C-glide, gold foil, DTL and skin electrodes. Eye (Lond) (1993) 0.99
Developmental changes in the human visual system as reflected by the latency of the pattern reversal VEP. Electroencephalogr Clin Neurophysiol (1983) 0.97
Development of ERG responses: the ISCEV rod, maximal and cone responses in normal subjects. Doc Ophthalmol (2003) 0.95
Development of the cone ERG in infants. Invest Ophthalmol Vis Sci (2005) 0.92
From immature to mature pattern ERG and VEP. Doc Ophthalmol (2003) 0.91
Comparison of ERGs recorded with skin and corneal-contact electrodes in normal children and adults. Doc Ophthalmol (2004) 0.89
The neonatal development of the light flash visual evoked potential. Doc Ophthalmol (1999) 0.89
Pattern ERG and VEP maturation in schoolchildren. Clin Neurophysiol (2002) 0.86
Prognostic value of flash visual evoked potentials in preterm infants. Dev Med Child Neurol (1999) 0.82
VEPs in normal full-term and premature neonates: longitudinal versus cross-sectional data. Electroencephalogr Clin Neurophysiol (1987) 0.81
Maturation of contrast EPs and development of visual resolution. Arch Ital Biol (1978) 0.81
Maturation of the pattern-reversal VEP in human infants: a theoretical framework. Vision Res (1999) 0.79
Development of pattern visual evoked potentials: longitudinal measurements in human infants. Optom Vis Sci (1997) 0.78
Implementing physician buy-in to practice guidelines. Med Interface (1995) 0.75
Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med (2009) 4.96
Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Doc Ophthalmol (2003) 3.59
Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet (2002) 2.94
CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia. Eur J Hum Genet (2005) 2.37
Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet (2005) 2.26
SOX2 anophthalmia syndrome. Am J Med Genet A (2005) 2.24
ISCEV standard for clinical electro-oculography (2010 update). Doc Ophthalmol (2011) 2.21
Genotyping microarray (disease chip) for Leber congenital amaurosis: detection of modifier alleles. Invest Ophthalmol Vis Sci (2005) 2.20
BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci (2002) 2.19
Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet (2002) 2.10
Foveal fine structure in retinopathy of prematurity: an adaptive optics Fourier domain optical coherence tomography study. Invest Ophthalmol Vis Sci (2008) 2.10
TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2009) 1.93
Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci (2005) 1.88
Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. Ophthalmology (2004) 1.74
FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet (2003) 1.70
The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res (2009) 1.41
Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies. PLoS One (2013) 1.40
Novel mutations in FRMD7 in X-linked congenital nystagmus. Mutation in brief #963. Online. Hum Mutat (2007) 1.38
Disease-causing 7.4 kb cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening. PLoS Genet (2009) 1.32
The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2006) 1.29
Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria. Arch Ophthalmol (2005) 1.28
Ophthalmological aspects of Pierson syndrome. Am J Ophthalmol (2008) 1.27
Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J Hum Genet (2003) 1.27
Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Graefes Arch Clin Exp Ophthalmol (2002) 1.26
X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15. Invest Ophthalmol Vis Sci (2003) 1.25
Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D. Hum Mutat (2002) 1.25
Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.25
Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci (2007) 1.24
Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P. Graefes Arch Clin Exp Ophthalmol (2006) 1.23
Role of SOX2 mutations in human hippocampal malformations and epilepsy. Epilepsia (2006) 1.22
Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther (2008) 1.20
Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol (2005) 1.19
The cone electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci (2008) 1.17
Oculo-auriculo-vertebral spectrum (OAVS): clinical evaluation and severity scoring of 53 patients and proposal for a new classification. Eur J Med Genet (2005) 1.15
The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci (2007) 1.15
Multifocal ERG in subjects with a history of retinopathy of prematurity. Doc Ophthalmol (2006) 1.14
Genotyping microarray for CSNB-associated genes. Invest Ophthalmol Vis Sci (2009) 1.10
Long-term effects of retinopathy of prematurity (ROP) on rod and rod-driven function. Doc Ophthalmol (2010) 1.09
Development of contrast sensitivity in infants with prenatal and neonatal thyroid hormone insufficiencies. Pediatr Res (2005) 1.08
Development of scotopic visual thresholds in retinopathy of prematurity. Invest Ophthalmol Vis Sci (2007) 1.07
Multimodal adaptive optics retinal imager: design and performance. J Opt Soc Am A Opt Image Sci Vis (2012) 1.07
Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response. Hum Mutat (2011) 1.06
Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis (2008) 1.05
The neurovascular relation in oxygen-induced retinopathy. Mol Vis (2008) 1.05
Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome. Arch Ophthalmol (2011) 1.04
Gene therapy for vision loss -- recent developments. Discov Med (2010) 1.04
Electroretinographic (ERG) responses in pediatric patients using vigabatrin. Doc Ophthalmol (2012) 1.03
Thirty distinct CACNA1F mutations in 33 families with incomplete type of XLCSNB and Cacna1f expression profiling in mouse retina. Eur J Hum Genet (2002) 1.03
Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci (2006) 1.03
Rod photoreceptor responses in children with Smith-Lemli-Opitz syndrome. Arch Ophthalmol (2003) 1.02
Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data. Graefes Arch Clin Exp Ophthalmol (2004) 1.01
Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism. Mol Vis (2011) 1.00
Retinal function in carriers of Bardet-Biedl syndrome. Arch Ophthalmol (2003) 1.00
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat (2003) 0.99
Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations. Graefes Arch Clin Exp Ophthalmol (2004) 0.98
The effect of broadband and monochromatic stimuli on the photopic negative response of the electroretinogram in normal subjects and in open-angle glaucoma patients. Doc Ophthalmol (2008) 0.97
Bilateral tonic pupils with evidence of anti-hu antibodies as a paraneoplastic manifestation of small cell lung cancer. Ophthalmologica (2004) 0.97
Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet (2003) 0.96
Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy. Antimicrob Agents Chemother (2010) 0.96
Effects of desferoxamine on retinal and visual function. Arch Ophthalmol (2007) 0.96
Development of ERG responses: the ISCEV rod, maximal and cone responses in normal subjects. Doc Ophthalmol (2003) 0.95
The characterization of retinal phenotype in a family with C1QTNF5-related late-onset retinal degeneration. Retina (2012) 0.95
Reduced visual function associated with infantile spasms in children on vigabatrin therapy. Invest Ophthalmol Vis Sci (2005) 0.95
Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia (2010) 0.94
The genetics and ocular findings of Alagille syndrome. Semin Ophthalmol (2007) 0.94
Novel causative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoform. Mol Vis (2008) 0.92
Development of the cone ERG in infants. Invest Ophthalmol Vis Sci (2005) 0.92
VEP maturation and visual acuity in infants and preschool children. Doc Ophthalmol (2008) 0.91
Misrouting of the optic nerves in albinism: estimation of the extent with visual evoked potentials. Invest Ophthalmol Vis Sci (2005) 0.91
Vision abnormalities in young children exposed prenatally to organic solvents. Neurotoxicology (2005) 0.91
The anatomy of the rat eye with oxygen-induced retinopathy. Doc Ophthalmol (2009) 0.91
Phenotypic diversity and mutation spectrum in hypotrichosis with juvenile macular dystrophy. J Invest Dermatol (2003) 0.91
Unilateral adult malignant optic nerve glioma. Graefes Arch Clin Exp Ophthalmol (2004) 0.91
Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data. Ophthalmology (2009) 0.90
Disturbed visual system function in methionine synthase deficiency. Graefes Arch Clin Exp Ophthalmol (2004) 0.90
Retinal degenerative and hypoxic ischemic disease. Doc Ophthalmol (2008) 0.90
Superior oblique tucking with versus without additional inferior oblique recession for acquired trochlear nerve palsy. Graefes Arch Clin Exp Ophthalmol (2009) 0.89
Longitudinal changes in photopic OPs occurring with vigabatrin treatment. Doc Ophthalmol (2003) 0.89
A novel p.Gly603Arg mutation in CACNA1F causes Åland island eye disease and incomplete congenital stationary night blindness phenotypes in a family. Mol Vis (2011) 0.89
Automated segmentation of pathological cavities in optical coherence tomography scans. Invest Ophthalmol Vis Sci (2013) 0.89
Fundus albipunctatus associated with compound heterozygous mutations in RPE65. Ophthalmology (2011) 0.89
RPGR: role in the photoreceptor cilium, human retinal disease, and gene therapy. Ophthalmic Genet (2010) 0.88
Lack of autofluorescence in fundus albipunctatus associated with mutations in RDH5. Retina (2010) 0.88
Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Invest Ophthalmol Vis Sci (2007) 0.88
Feasibility and outcome of automated kinetic perimetry in children. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Visual fields in young children treated with vigabatrin. Optom Vis Sci (2009) 0.88
Visual evoked potentials to red-green stimulation in schoolchildren. Vis Neurosci (2006) 0.87
Assessment of central retinal function in patients with advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci (2007) 0.87
Rod photoreceptor function in children with mitochondrial disorders. Arch Ophthalmol (2002) 0.87
Automated segmentation of retinal blood vessels in spectral domain optical coherence tomography scans. Biomed Opt Express (2012) 0.87
Rod and rod-driven function in achromatopsia and blue cone monochromatism. Invest Ophthalmol Vis Sci (2008) 0.86
Development of visual acuity in children with cerebral visual impairment. Arch Ophthalmol (2005) 0.85
Recovery of the rod photoresponse in infants. Invest Ophthalmol Vis Sci (2005) 0.85
ERG oscillatory potentials in infants. Doc Ophthalmol (2005) 0.85